Neurogene
NGNE
NGNE
50 hedge funds and large institutions have $302M invested in Neurogene in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 21 increasing their positions, 12 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
4% less funds holding
Funds holding: 52 → 50 (-2)
22% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 9
45% less call options, than puts
Call options by funds: $2.33M | Put options by funds: $4.24M
Holders
50
Holding in Top 10
1
Calls
$2.33M
Puts
$4.24M
Top Buyers
| 1 | +$6.12M | |
| 2 | +$5.07M | |
| 3 | +$3.52M | |
| 4 |
Morgan Stanley
New York
|
+$1.1M |
| 5 |
MWNA
Marshall Wace North America
New York
|
+$806K |
Top Sellers
| 1 | -$11.3M | |
| 2 | -$3M | |
| 3 | -$2.54M | |
| 4 |
UONDDL
University of Notre Dame du Lac
South Bend,
Indiana
|
-$1.59M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.06M |